ABEO

ABEO R&D to Revenue

460.69%Fiscal year

Period ending:

ABEO FY R&D/Revenue%
ABEO FY R&D/Revenue12006.40%-1286.40%
1995-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

ABEO r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 31 observations from Dec 31, 1995 to Dec 31, 2025.

Abeona Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
460.6873%
0%
888.3143%
2,048.4441%
1,290.8667%
301.39%
0%
1,290.7939%
2,029.7491%
1,198.5377%
453.3654%
36%
43.2909%
45.6403%
193.6688%
696.2578%
754.8295%
4,334.3643%
4,564.9123%
0%
0%
425.3188%
196.834%
612.3801%
1,717.6955%
3,744.8598%
10,720%
1,800%
559.3103%
841.3174%
42.5467%

Compare r&d to revenue

All ABEO financial metrics · ABEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.